Updated:
Eurazeo North America
Eurazeo North America is the US private equity and venture capital arm of French-listed Eurazeo SE, investing in technology, healthcare, and financial...
Eurazeo North America
Eurazeo North America was formally launched in 2019 as a subsidiary of Eurazeo SE, the Paris-based listed investment company founded in 1999 and managed by Virginie Morgon. The North American office serves as the firm's primary platform for sourcing and executing private equity, venture capital, and growth equity transactions across the United States and Canada. Eurazeo North America invests across a range of asset classes including buyout, growth equity, and venture capital. The firm targets technology, healthcare, financial services, and business services sectors. Portfolio companies held through the broader Eurazeo network include WorldStrides, I-TRACING, and the B&B Hotels chain. The North American team deploys capital both directly and through co-investments alongside other institutional partners, with a geographic focus on the US and select Canadian markets. Eurazeo SE reported over €35 billion in assets under management as of year-end 2025, though the North American unit's specific AUM is not broken out separately. The group employs roughly 350 professionals globally, with a small dedicated North American team based in New York. The broader Eurazeo structure includes the Eurazeo Foundation, which manages philanthropic initiatives, and the firm operates through multiple fund vehicles including dedicated private equity, venture, and growth funds. A structural differentiator is Eurazeo's hybrid model as a listed investment company (Euronext: RF) rather than a traditional closed-end partnership. This publicly traded structure provides permanent capital and allows the North American arm to pursue longer-dated holdings without the constraints of fixed fund life cycles, giving them a flexibility edge over conventional PE firms in the region.
General information
Firm type
Asset Manager
Year founded
2019
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Sector focus
Frequently asked questions
Who manages investment decisions at Eurazeo North America?
The North American team operates under the broader Eurazeo SE investment committee, historically led by CEO Virginie Morgon at the group level. Specific regional leadership for the North American office has not been publicly named, but investment decisions follow Eurazeo's process across private equity, venture, and growth equity.
Is Eurazeo North America structured as a separate fund or a division of the parent?
Eurazeo North America is a division of Eurazeo SE, the publicly traded French investment company. It is not a separate fund with its own LPs; rather, it deploys capital from Eurazeo's permanent capital base and from its managed fund vehicles on behalf of institutional investors. This structure allows the North American team to hold assets for indefinite periods if the investment thesis requires.
What investment stages does Eurazeo North America target?
The firm targets a full spectrum including buyout, growth equity, and venture capital. It focuses on established companies with proven business models as well as earlier-growth-stage firms in the technology, healthcare, and financial services sectors. The platform is structured to lead or co-lead transactions ranging from $50 million to several hundred million dollars.
How does Eurazeo North America source deal flow?
Deal sourcing leverages the Eurazeo group's 25-year track record and its network of portfolio companies, investment bankers, and industry executives across Europe and North America. The team also benefits from proprietary deal flow generated by Eurazeo's sector-focused teams in technology, healthcare, and financial services, as well as co-investment relationships with other institutional investors.
Where does the underlying wealth for Eurazeo come from?
Eurazeo SE is a publicly listed investment company on Euronext Paris, so its capital base comes from shareholders and institutional investors who buy its stock. The parent company manages funds for third-party investors alongside its own balance sheet. Eurazeo North America draws on this institutional capital rather than any single-family wealth.
What is Eurazeo's relationship to other Eurazeo entities like Idinvest?
Eurazeo acquired Idinvest, a French private debt and venture capital firm, in 2018, and the combined group operates under the Eurazeo brand. Idinvest's legacy venture and private debt activities are integrated into Eurazeo's broader platform, while the North American unit focuses on direct private equity and growth investments. The group's structure encompasses multiple specialized teams under a single management umbrella.
Does Eurazeo North America participate in syndicated deals or only lead investments?
Eurazeo North America both leads and participates in syndicated transactions. The firm's permanent capital base allows it to anchor large buyouts while also taking minority positions in growth companies alongside other financial sponsors. Co-investment partnerships with other institutions are a regular part of the investment strategy, particularly in transactions requiring deal-specific expertise.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on registered investment advisers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: